InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,427.74
(
-0.73%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: Opti Mist post# 2615

Wednesday, 06/07/2017 9:28:04 AM

Wednesday, June 07, 2017 9:28:04 AM

Post# of 4273
FDA accepts Synergy's marketing application for expanded use of Trulance; shares ahead 4% premarket
Jun. 7, 2017 9:18 AM • SA Editor Douglas W. House

The FDA accepts for review Synergy Pharmaceuticals' (NASDAQ:SGYP) supplemental New Drug Application (sNDA) seeking approval of TRULANCE (plecanatide) for the treatment of irritable bowel syndrome with constipation (IBS-C). The agency's action date (PDUFA) is January 24, 2018.
The FDA approved TRULANCE to treat chronic idiopathic constipation in January.
Share are up 4% premarket on increased volume.

https://seekingalpha.com/news/3272094-fda-accepts-synergys-marketing-application-expanded-use-trulance-shares-ahead-4-percent
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up